Movement Alert|SERES rises 3.14% in Regular Trading, buyback progress and October sales update support sentiment

Market Focus11-02

On November 2, SERES rose 3.14% in Regular Trading, trading at HK$30.2, with turnover of HK$8.758 million.

The clearest fresh catalyst was a cluster of company updates released on November 1, including October vehicle sales and the latest share buyback progress. SERES said October vehicle sales were about 27,000 units, while January-October sales reached about 310,200 units. The company also disclosed that it had repurchased 17.54 million shares, equal to 1.01% of total share capital, for about RMB983 million, close to the lower bound of its RMB1 billion to RMB2 billion buyback plan, with all repurchased shares intended for cancellation.

These updates followed the companys third-quarter results released on October 30, when quarterly revenue was RMB28.08 billion and net profit was RMB1.42 billion, although October new energy vehicle sales still showed a sharp year-on-year decline. The mix of capital return, ongoing cancellation plans, and recent profitability appears to provide a reasonable explanation for the move.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment